SCHEMBL5397128

SCHEMBL5397128

CCC(=Cc1cn(Cc2ccc(OCc3ccccc3)cc2)nc1-c1ccccc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.52
▸ SMN1; SMN2 Q16637 5/20 0.52
▸ RAB9A P51151 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ PKM P14618 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ PTGS1 P23219 2/20 0.45
▸ PTGS2 P35354 2/20 0.45
▸ LTB4R Q15722 1/20 0.45
▸ LTB4R2 Q9NPC1 1/20 0.45
▸ PTGDR2 Q9Y5Y4 1/20 0.45
▸ PLK1 P53350 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ PSEN1 P49768 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5381943 0.94 SMN1; SMN2 (0.50) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5376873 0.88 PTGDR2 (0.46) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5377146 0.82 LTB4R (0.44) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5376726 0.82 GAA (0.79) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5376722 0.82 GAA (0.79) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5374881 0.81 LTB4R (0.47) GAASMN1; SMN2RAB9ANPC1MAPT
SCHEMBL5397126 0.81 GAA (0.61) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5382578 0.79 ALDH1A1 (0.47) GAASMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5380793 0.79 FFAR1 (0.52) MAPT
SCHEMBL5378962 0.78 KMT2A (0.64) GAALMNAKMT2APKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 — — US disclosed
Send feedback